Pharmaceutical industry – Page 9
-
Opinion
The law of conservation of data
AI and machine learning are useful and powerful, but they need high quality data inputs that aren’t available yet for drug discovery
-
Business
US judge overturns Purdue’s opioid bankruptcy settlement
Ruling says bankruptcy court did not have authority to grant Sackler family protection from future litigation
-
Opinion
When regulatory cooperation goes too far, we all lose
Were FDA staff unduly influenced by Biogen in approving Alzheimer’s antibody?
-
Business
Pharmaceuticals roundup 2021
It’s been another dramatic, pandemic-dominated year for the pharmaceutical industry
-
Webinar
Using flow chemistry to give early drug discovery processes a boost
Discover how pioneering modular flow chemistry technologies can unlock the potential for discovery chemists to accelerate research
-
Business
Diversity is at the heart of innovation
To challenge conventions we need to include people who think differently
-
Business
Pfizer sues former employee for alleged trade secret theft
Chun Xiao Li downloaded thousands of confidential documents before resigning
-
Opinion
A red pill for green medicines
The pharmaceutical industry is taking action towards net zero
-
Business
Covid-19 antivirals surge forward
Promising results from Pfizer trial, while UK approves Merck & Co’s molnupiravir
-
Opinion
All work and no play
Is the long-hours culture of academic organic chemistry laboratories finally changing?
-
Article
Facilitating the future
A view from the top at Johnson Matthey on the future of drug development
-
Business
Predicting and preventing production losses with AI
Seebo’s machine learning technology helps chemical manufacturers get deep insight into their processes
-
Article
AstraZeneca explores new frontiers through academic collaborations
The important of partnerships between industry and academia to drive innovation
-
Business
New antiviral impresses against Covid-19
Merck & Co and Ridgeback’s molnupiravir reduces risk of hospitalisation and death, and may work against other coronaviruses
-
Opinion
Where are the Covid-19 drugs?
Small molecules appear to be lagging behind development of vaccine and antibody treatments
-
Business
Fully synthetic proteins make tailored medicines
Bright Peak Therapeutics makes modified protein drugs from scratch
-
Webinar
Unlock the potential of definitive screening designs to drive your projects forward
In this webinar we help demystify DSDs and reveal how their complexity can be harnessed for manufacturing processes
-
Business
The future of ‘next generation’ DNA sequencing
As it gets cheaper and easier to read genetic code, its applications are expanding rapidly
-
Business
US judge accepts Purdue’s opioid bankruptcy settlement plan
Deal releases $4.3bn to combat addiction, but protects Sackler family from litigation
-
Business
US grants Pfizer’s Covid-19 vaccine full approval
WHO calls for delay to booster programmes to allow more global distribution